Grow Your Wealth
with Mutual Funds
HDFC Pharma And Healthcare Fund Direct-growth
Equity
Mid Cap
Very High Risk
Latest AUM
₹ 2,611.3 Cr.
NAV as on 03 aug, 2026
₹ 21.99
+20.58%
3 years annulised
This Fund
Fund Details
Fund Names
HDFC Pharma And Healthcare Fund Direct-growth
Inception Date
04 Oct 2023
Lock In
No Lock-in
SIP Minimum Investment amount
₹100
SWP Minimum Investment amount
₹100
STP Minimum Investment amount
₹500
Risk
Principal at very high risk
Category Average Annual Returns
6.04
Portfolio Composition Analysis
Equity
97.25%
Cash
2.75%
Portfolio Updated on: 10 Jul, 2026
Sector Allocations
Equity
Healthcare
Industrials
Portfolio Updated on: 03 aug, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.96% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.96% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.34% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.20% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.79% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.70% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.70% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.20% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.81% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.39% |
Debt & Credit Risk Analysis
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 16.89% | NA | 6.12% |
| 6 Months | 27.41% | NA | 12.92% |
| 9 Months | 22.17% | NA | 4.47% |
| 1 Year | 24.24% | 24.24% | 6.04% |
| 2 Years | 47.14% | 21.30% | 24.93% |
HDFC Pharma And Healthcare Fund Direct-growth is one Equity mutual fund offered by HDFC Mutual Fund. Launched on 04 Oct 2023, the fund aims To generate long-term capital appreciation Investment predominantly in equity & equity related instruments of Pharma and healthcare companies. It manages assets worth ₹2,611.3 crore as on Tue Jun 30, 2026. The expense ratio stands at 1.11%.
Dhruv Muchhal has experience Prior to joining HDFC MF,he has worked with Motilal Oswal Financial Services Ltd., Goldman Sachs, CRISIL Global Research & Analytics and Deloitte Haskins & Sells
Nikhil Mathur has experience Prior to joining HDFC Mutual Fund, he has worked with Ambit Capital, Goldman Sachs, Deloitte India and EY
Top Performing Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,997.7 | +2.81% | +17.48% | +25.25% | +20.07% | +24.60% | +17.98% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw | 4,997.7 | +2.81% | +17.48% | +25.25% | +20.07% | +24.60% | +17.98% |
| SBI Healthcare Opportunities Fund-growth | 4,997.7 | +2.72% | +17.19% | +24.63% | +18.87% | +23.32% | +16.75% |
| SBI Healthcare Opportunities Fund-idcw | 4,997.7 | +2.72% | +17.19% | +24.63% | +18.87% | +23.32% | +16.75% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,624.6 | +0.97% | +10.20% | +15.47% | +10.98% | +24.03% | +16.63% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,624.6 | +0.97% | +10.20% | +15.47% | +10.98% | +24.03% | +16.63% |
| DSP Healthcare Fund Direct-growth | 3,514.0 | +2.43% | +13.63% | +18.99% | +10.81% | +21.00% | +15.99% |
| DSP Healthcare Fund Direct-idcw | 3,514.0 | +2.43% | +13.63% | +18.99% | +10.81% | +21.00% | +15.99% |
| Mirae Asset Healthcare Fund Direct-growth | 3,252.5 | +3.07% | +14.10% | +24.01% | +19.66% | +23.87% | +15.83% |
| Mirae Asset Healthcare Fund Direct-idcw | 3,252.5 | +3.07% | +14.10% | +24.01% | +19.66% | +23.87% | +15.83% |
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from HDFC Mutual Fund
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| HDFC Pharma And Healthcare Fund Regular-growth | 2,611.3 | +2.63% | +16.56% | +26.71% | +22.83% | — | — |
| HDFC Pharma And Healthcare Fund Regular-idcw | 2,611.3 | +2.63% | +16.56% | +26.71% | +22.83% | — | — |
| HDFC Pharma And Healthcare Fund Direct-idcw | 2,611.3 | +2.72% | +16.89% | +27.41% | +24.24% | — | — |
growth is based on 1-month returns of the funds
Top Mutual Funds
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹595.67 | +24.60% | +17.98% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹413.85 | +24.60% | +17.98% | — |
| Sbi Healthcare Opportunities Fund-growth | ₹514.75 | +23.32% | +16.75% | — |
| Sbi Healthcare Opportunities Fund-idcw | ₹324.27 | +23.32% | +16.75% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹47.77 | +24.03% | +16.63% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹28.85 | +24.03% | +16.63% | — |
| Dsp Healthcare Fund Direct-growth | ₹49.33 | +21.00% | +15.99% | — |
| Dsp Healthcare Fund Direct-idcw | ₹28.53 | +21.00% | +15.99% | — |
| Mirae Asset Healthcare Fund Direct-growth | ₹51.65 | +23.87% | +15.83% | — |
| Mirae Asset Healthcare Fund Direct-idcw | ₹31.11 | +23.87% | +15.83% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 03 Aug 2026 | ₹21.99 |
| 31 Jul 2026 | ₹21.79 |
| 30 Jul 2026 | ₹21.77 |
| 29 Jul 2026 | ₹21.84 |
| 28 Jul 2026 | ₹21.54 |
| 27 Jul 2026 | ₹21.57 |
| 24 Jul 2026 | ₹21.25 |
| 23 Jul 2026 | ₹21.30 |
| 22 Jul 2026 | ₹21.45 |
| 21 Jul 2026 | ₹21.76 |
| 20 Jul 2026 | ₹21.72 |
| 17 Jul 2026 | ₹21.51 |
| 16 Jul 2026 | ₹21.70 |
| 15 Jul 2026 | ₹21.67 |
| 14 Jul 2026 | ₹21.49 |
| 13 Jul 2026 | ₹21.36 |
| 10 Jul 2026 | ₹21.35 |
| 09 Jul 2026 | ₹21.31 |
| 08 Jul 2026 | ₹20.99 |
| 07 Jul 2026 | ₹21.22 |
| 06 Jul 2026 | ₹21.39 |
| 03 Jul 2026 | ₹21.41 |
| 02 Jul 2026 | ₹21.22 |
| 01 Jul 2026 | ₹21.03 |
| 30 Jun 2026 | ₹21.08 |
| 29 Jun 2026 | ₹20.92 |
| 25 Jun 2026 | ₹20.75 |
| 24 Jun 2026 | ₹20.81 |
| 23 Jun 2026 | ₹20.79 |
| 22 Jun 2026 | ₹20.66 |
Portfolio Updated on: 04 Aug, 2026
Fund Growth & Size Analysis
+₹2,611.3 Cr
Since Launch
This Fund
Category Average
Compare Mutual funds
HDFC Pharma And Healthcare Fund Direct-growth Returns Comparison
Compare HDFC Pharma And Healthcare Fund Direct-growth with any MF,
EYF, stock or index
Jan 1, 2026 – Feb 1, 2026
HDFC Pharma And Health....
No funds found for your search.
